retatrutide eli lilly phase 2 results orforglipron oral GLP-1 3 weight loss trial retatrutide weight loss phase 2

37 The SUMMIT trial provides further evidence of the usefulness of GLP-1RAs in HF

The label is candid that available data are insufficient to say whether modifying fasting recommendations or temporarily pausing treatment would reduce that risk

It also supports the intestinal barrier function and promotes healthy inflammatory markers

So its no surprise that the supplement industry is trying to cash in on the drugs success

For readers who want to explore the full biological network, our Akkermansia microbiome hub explains how the oral microbiome, gut barrier and intestinal lining health , and metabolic signaling are interconnected

20 February 2024